Integra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to Integra LifeSciences Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides 2020 Financial Guidance

Integra LifeSciences (IART) Tops Q4 EPS by 1c, Revenues Miss; Offers FY20 EPS Mid-Point Guidance Above Consensus, FY20 Revenue Outlook Below Consensus

February 19, 2020 6:08 AM EST

Integra LifeSciences (NASDAQ: IART) reported Q4 EPS of $0.68, $0.01 better than the analyst estimate of $0.67. Revenue for the quarter came in at $395.1 million versus the consensus estimate of $397.5 million.

Fourth Quarter 2019

Reported revenue increased 3.1% to $395.1 million and organic sales increased 4.6% over the fourth... More